Peripheral Histamine 1 Receptor Blockade in IBS

Trial Profile

Peripheral Histamine 1 Receptor Blockade in IBS

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Feb 2017

At a glance

  • Drugs Ebastine (Primary)
  • Indications Irritable bowel syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Dec 2015 Planned End Date changed from 1 Mar 2016 to 1 Mar 2018 as reported by ClinicalTrials.gov record.
    • 02 Dec 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Oct 2017 as reported by ClinicalTrials.gov record.
    • 11 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top